Get started
NATH BIO-GENES (I) LTDNATH BIO-GENES (I) LTDNATH BIO-GENES (I) LTD

NATH BIO-GENES (I) LTD

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

NATHBIOGEN chart


Full chart

NATHBIOGEN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.51 B‬ INR
Dividend yield (indicated)
1.06%
Price to earnings Ratio (TTM)
9.56
Basic EPS (TTM)
19.71 INR
Net income (FY)
‪396.19 M‬ INR
Revenue (FY)
‪2.48 B‬ INR
Shares float
‪7.29 M‬
Beta (1Y)
1.06

Employees


Employees (FY)
423
Change (1Y)
−10 −2.31%
Revenue / Employee (1Y)
‪5.85 M‬ INR
Net income / Employee (1Y)
‪936.61 K‬ INR

About NATH BIO-GENES (I) LTD


Sector
Process Industries
Industry
Agricultural Commodities/Milling
CEO
Satish Laxminarayan Kagliwal
Website
nathbiogenes.com
Headquarters
Mumbai
Founded
1993
ISIN
INE448G01010
FIGI
BBG005XNKKG7
Nath Bio-Genes (India) Ltd. engages in the production and marketing of seeds. The firm offers categories of seeds including cereals, fiber and oil seeds, nutritional supplements, and vegetables. It operates through the Agriculture Activities and Trading Activities segments. The company was founded on July 14, 1993 and is headquartered in Aurangabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NATHBIOGEN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NATHBIOGEN is 184.88 INR — it has decreased by −1.93% in the past 24 hours. Watch NATH BIO-GENES (I) LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange NATH BIO-GENES (I) LTD stocks are traded under the ticker NATHBIOGEN.
NATHBIOGEN stock has fallen by −6.67% compared to the previous week, the month change is a 5.40% rise, over the last year NATH BIO-GENES (I) LTD has showed a −8.59% decrease.
NATHBIOGEN reached its all-time high on May 10, 2018 with the price of 585.00 INR, and its all-time low was 20.00 INR and was reached on Jan 28, 2014. View more price dynamics on NATHBIOGEN chart.
See other stocks reaching their highest and lowest prices.
NATHBIOGEN stock is 5.53% volatile and has beta coefficient of 1.06. Track NATH BIO-GENES (I) LTD stock price on the chart and check out the list of the most volatile stocks — is NATH BIO-GENES (I) LTD there?
Today NATH BIO-GENES (I) LTD has the market capitalization of ‪3.51 B‬, it has decreased by −4.33% over the last week.
Yes, you can track NATH BIO-GENES (I) LTD financials in yearly and quarterly reports right on TradingView.
NATH BIO-GENES (I) LTD is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
NATHBIOGEN net income for the last quarter is ‪11.13 M‬ INR, while the quarter before that showed ‪333.55 M‬ INR of net income which accounts for −96.66% change. Track more NATH BIO-GENES (I) LTD financial stats to get the full picture.
Yes, NATHBIOGEN dividends are paid annually. The last dividend per share was 2.00 INR. As of today, Dividend Yield (TTM)% is 1.08%. Tracking NATH BIO-GENES (I) LTD dividends might help you take more informed decisions.
NATH BIO-GENES (I) LTD dividend yield was 1.15% in 2023, and payout ratio reached 9.59%. The year before the numbers were 1.41% and 10.86% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 423.00 employees. See our rating of the largest employees — is NATH BIO-GENES (I) LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATH BIO-GENES (I) LTD EBITDA is ‪509.22 M‬ INR, and current EBITDA margin is 20.59%. See more stats in NATH BIO-GENES (I) LTD financial statements.
Like other stocks, NATHBIOGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATH BIO-GENES (I) LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATH BIO-GENES (I) LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATH BIO-GENES (I) LTD stock shows the sell signal. See more of NATH BIO-GENES (I) LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.